News - MammaPrint
2012-03-22 12:40:21
Testing a breast cancer tumor for its genomic signature can help identify which patients will need adjuvant systemic therapy (additional chemotherapy) after surgery, and spare its use in those for whom it is not necessary.
2012-01-09 06:00:00
IRVINE, Calif. and AMSTERDAM, Jan. 9, 2012 /PRNewswire/ -- Agendia, an innovative molecular cancer diagnostics company, today announced that Peter C.